IL17A and systemic lupus erythematosus: We report that hUCMSC-EVs at least partly mimic the immunomodulatory effects of MSCs in SLE, such as inhibiting CD4+ T cells, promoting Th17 cells, and increasing the production of IL-17 and TGF-β1.